Cork's NeuroBell secures €5m in new funding for US launch

UCC spin-out's device detects seizures in newborns

Colm Murphy, CTO, NeuroBell, Olive O'Driscoll, Chairperson, NeuroBell, Dr Alison O'Shea, CSO, NeuroBell, Dara O'Shea, Senior Investment Associate, Elkstone and Dr Mark O'Sullivan, CEO.

Cork medical technology company NeuroBell has secured $5.5m (€4.8m) in investment to accelerate the launch of its LUNA neonatal brain monitor in the US.

NeuroBell, co-founded by Dr Mark O’Sullivan, Dr Alison O’Shea and Colm Murphy, spun out from University College Cork in 2023, after nearly a decade of academic research into newborn brain health.